On consolidated basis
Quarter ended December 2024 compared with Quarter ended December 2023.
Net sales (including other operating income) of Kopran has increased 4.61% to Rs 166.24 crore. Operating profit margin has declined from 14.84% to 11.94%, leading to 15.82% decline in operating profit to Rs 19.85 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 65.63% to 61.35%. Purchase of finished goods cost fell from 1.36% to 0.27%. Employee cost increased from 8.28% to 9.77%. Other expenses rose from 13.24% to 16.04%. Other income fell 93% to Rs 0.17 crore. PBIDT fell 23.03% to Rs 20.02 crore. Provision for interest fell 3.57% to Rs 2.16 crore. PBDT fell 24.86% to Rs 17.86 crore. Provision for depreciation rose 22.32% to Rs 4 crore. Profit before tax down 32.39% to Rs 13.86 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 3.46 crore, compared to Rs 4.71 crore. Effective tax rate was 24.96% compared to 22.98%. Minority interest was nil in both the periods. Net profit attributable to owners of the company decreased 34.14% to Rs 10.40 crore. Promoters’ stake was 44.45% as of 31 December 2024 ,compared to 44.49% as of 31 December 2023 .
For year-to-date (YTD) results analysis.
Net sales (including other operating income) of Kopran has increased 6.70% to Rs 457.24 crore. Operating profit margin has declined from 12.30% to 12.03%, leading to 4.34% rise in operating profit to Rs 55.01 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 65.32% to 63.20%. Purchase of finished goods cost rose from 0.24% to 0.41%. Employee cost increased from 8.90% to 9.37%. Other expenses rose from 14.09% to 15.10%. Other income fell 69.29% to Rs 1.52 crore. PBIDT fell 1.98% to Rs 56.53 crore. Provision for interest rose 9.32% to Rs 6.57 crore. PBDT fell 3.29% to Rs 49.96 crore. Provision for depreciation rose 26.26% to Rs 11.73 crore. Profit before tax down 9.77% to Rs 38.23 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 9.36 crore, compared to Rs 10.03 crore. Effective tax rate was 24.48% compared to 23.67%.Minority interest was nil in both the periods. Net profit attributable to owners of the company decreased 10.73% to Rs 28.87 crore. Promoters’ stake was 44.45% as of 31 December 2024 ,compared to 44.49% as of 31 December 2023 .
Full year results analysis.
Net sales (including other operating income) of Kopran has increased 11.54% to Rs 614.59 crore. Operating profit margin has jumped from 9.40% to 12.11%, leading to 43.72% rise in operating profit to Rs 74.42 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 60.17% to 64.36%. Purchase of finished goods cost fell from 4.52% to 0.98%. Employee cost decreased from 9.28% to 8.52%. Other expenses fell from 16.41% to 14.01%. Other income rose 375.90% to Rs 14.61 crore. PBIDT rose 62.32% to Rs 89.03 crore. Provision for interest rose 41.28% to Rs 8.59 crore. Loan funds rose to Rs 99.23 crore as of 31 March 2024 from Rs 75.24 crore as of 31 March 2023. Inventories rose to Rs 138.49 crore as of 31 March 2024 from Rs 130.61 crore as of 31 March 2023. Sundry debtors were higher at Rs 212.33 crore as of 31 March 2024 compared to Rs 162.56 crore as of 31 March 2023. Cash and bank balance rose to Rs 14.20 crore as of 31 March 2024 from Rs 12.58 crore as of 31 March 2023. Investments stood at Rs 0.06 crore as of 31 March 2024 to Rs 0.06 crore as of 31 March 2023. PBDT rose 64.94% to Rs 80.44 crore. Provision for depreciation rose 1.42% to Rs 12.89 crore. Fixed assets increased to Rs 278.29 crore as of 31 March 2024 from Rs 234.57 crore as of 31 March 2023. Intangible assets stood at Rs 0.01 crore. Profit before tax grew 87.33% to Rs 67.55 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 16.59 crore, compared to Rs 8.83 crore. Effective tax rate was 24.56% compared to 24.49%. Minority interest was nil in both the periods. Net profit attributable to owners of the company increased 87.15% to Rs 50.96 crore. Equity capital stood at Rs 48.21 crore as of 31 March 2024 to Rs 48.21 crore as of 31 March 2023. Per share face Value remained same at Rs 10.00. Promoters’ stake was 44.49% as of 31 March 2024 ,compared to 44.30% as of 31 March 2023 . Cash flow from operating activities increased to Rs 43.26 crore for year ended March 2024 from Rs 34.02 crore for year ended March 2023. Cash flow used in acquiring fixed assets during the year ended March 2024 stood at Rs 56.61 crore, compared to Rs 61.05 crore during the year ended March 2023. Business highlights
In Q3 FY25, Anti-hypertensive contributed 13% to API
revenue, Antibiotic-Urological 10%, Anti-Thrombotic 4.5%, Carbapenem 49%,
Intermediate 4.5%, Macrolide 9%, Neuromodulator 7.5%, Steriles Cepholosphorin
2.8%, and others 0.3%.
In 9M FY25, exports contributed 43% to API sales and
domestic 57%.
| Kopran : Consolidated Results | | | Quarter ended | Year to Date | Year ended |
|---|
| Particulars | 202412 | 202312 | Var.(%) | 202412 | 202312 | Var.(%) | 202403 | 202303 | Var.(%) |
|---|
| Net Sales (including other operating income) | 166.24 | 158.92 | 4.61 | 457.24 | 428.51 | 6.70 | 614.59 | 550.99 | 11.54 | | OPM (%) | 11.94 | 14.84 | -290 bps | 12.03 | 12.30 | -27 bps | 12.11 | 9.40 | 271 bps | | OP | 19.85 | 23.58 | -15.82 | 55.01 | 52.72 | 4.34 | 74.42 | 51.78 | 43.72 | | Other Inc. | 0.17 | 2.43 | -93.00 | 1.52 | 4.95 | -69.29 | 14.61 | 3.07 | 375.90 | | PBIDT | 20.02 | 26.01 | -23.03 | 56.53 | 57.67 | -1.98 | 89.03 | 54.85 | 62.32 | | Interest | 2.16 | 2.24 | -3.57 | 6.57 | 6.01 | 9.32 | 8.59 | 6.08 | 41.28 | | PBDT | 17.86 | 23.77 | -24.86 | 49.96 | 51.66 | -3.29 | 80.44 | 48.77 | 64.94 | | Depreciation | 4 | 3.27 | 22.32 | 11.73 | 9.29 | 26.26 | 12.89 | 12.71 | 1.42 | | PBT | 13.86 | 20.50 | -32.39 | 38.23 | 42.37 | -9.77 | 67.55 | 36.06 | 87.33 | | Share of Profit/(Loss) from Associates | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | PBT before EO | 13.86 | 20.5 | -32.39 | 38.23 | 42.37 | -9.77 | 67.55 | 36.06 | 87.33 | | EO Income | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | PBT after EO | 13.86 | 20.5 | -32.39 | 38.23 | 42.37 | -9.77 | 67.55 | 36.06 | 87.33 | | Taxation | 3.46 | 4.71 | -26.54 | 9.36 | 10.03 | -6.68 | 16.59 | 8.83 | 87.88 | | PAT | 10.4 | 15.79 | -34.14 | 28.87 | 32.34 | -10.73 | 50.96 | 27.23 | 87.15 | | Minority Interest (MI) | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit | 10.4 | 15.79 | -34.14 | 28.87 | 32.34 | -10.73 | 50.96 | 27.23 | 87.15 | | P/(L) from discontinued operations net of tax | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit after discontinued operations | 10.4 | 15.79 | -34.14 | 28.87 | 32.34 | -10.73 | 50.96 | 27.23 | 87.15 | | EPS (Rs)* | 2.15 | 3.27 | -34.14 | 5.98 | 6.70 | -10.73 | 10.55 | 5.64 | 87.15 | | | * EPS is on current equity of Rs 48.29 crore, Face value of Rs 10, Excluding extraordinary items. | | # EPS is not annualised | | bps : Basis points | | EO : Extraordinary items | | Figures in Rs crore | | Source: Capitaline Corporate Database |
|
|